Literature DB >> 33305989

Rapid ESBL NP Test for Rapid Detection of Expanded-Spectrum β-Lactamase Producers in Enterobacterales.

Anthony Demord1,2, Laurent Poirel1,2,3, Fernando D'Emidio4, Stefano Pomponio4, Patrice Nordmann1,2,3,5.   

Abstract

Objectives: To evaluate the biochemical Rapid ESBL NP® (Liofilchem, Italy) for the rapid detection of extended-spectrum β-lactamases (ESBLs) in Enterobacterales.
Methods: A total of 100 clinical gram-negative strains (40 ESBL producers with or without cephalosporinase, 43 carbapenemase producers with or without additional ESBLs, 8 AmpC-type producers, 6 penicillinase producers, and 3 non-β-lactamase producers) were tested using this colorimetric technique.
Results: The overall sensitivity and specificity of the test were found to be 93.9% and 98.5%, respectively. This test is rapid (turn-around-time of 40-45 minutes), easy to perform, and reliable for identification of ESBL producers.
Conclusion: The Rapid ESBL NP test allows differentiation between ESBL producers on one hand, and non-ESBL producers or isolates expressing combined mechanisms of resistance on the other hand.

Entities:  

Keywords:  ESBL; Enterobacterales; gram-negatives; rapid diagnostic

Mesh:

Substances:

Year:  2020        PMID: 33305989     DOI: 10.1089/mdr.2020.0391

Source DB:  PubMed          Journal:  Microb Drug Resist        ISSN: 1076-6294            Impact factor:   3.431


  2 in total

1.  Association of multidrug resistance behavior of clinical Pseudomonas aeruginosa to pigment coloration.

Authors:  Ashish Kothari; Shyam Kishor Kumar; Vanya Singh; Prashant Kumar; Karanvir Kaushal; Atul Pandey; Neeraj Jain; Balram Ji Omar
Journal:  Eur J Med Res       Date:  2022-07-16       Impact factor: 4.981

2.  Direct detection of extended-spectrum-β-lactamase-producers in Enterobacterales from blood cultures: a comparative analysis.

Authors:  Matteo Boattini; Gabriele Bianco; Sara Comini; Marco Iannaccone; Roberto Casale; Rossana Cavallo; Patrice Nordmann; Cristina Costa
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2021-11-25       Impact factor: 5.103

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.